Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 9
Submit an article Journal homepage
68
Views
7
CrossRef citations to date
0
Altmetric
Letter to the Editor

Hepatitis B virus reactivation induced by Yttrium-90-ibritumomab-tiuxetan

Timucin Cil Department of Medical OncologyCorrespondence[email protected]
,
Abdullah Altintas Department of Hematology
,
Yekta Tuzun Department of Gastroenterology, Internal Medicine, Dicle University, Diyarbakir, Turkey
,
Semir Pasa Department of Hematology
&
Abdurrahman Isikdogan Department of Medical Oncology
Pages 1866-1868 | Received 07 Jun 2007, Accepted 12 Jun 2007, Published online: 01 Jul 2009

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shang-Chin Huang, Hung-Chih Yang & Jia-Horng Kao. (2020) Hepatitis B reactivation: diagnosis and management. Expert Review of Gastroenterology & Hepatology 14:7, pages 565-578.
Read now
Kirsty Wai-Chung Lee & Stephen Lam Chan. (2016) Hepatotoxicity of targeted therapy for cancer. Expert Opinion on Drug Metabolism & Toxicology 12:7, pages 789-802.
Read now

Articles from other publishers (5)

Anil Seetharam, Robert Perrillo & Robert Gish. (2014) Immunosuppression in Patients with Chronic Hepatitis B. Current Hepatology Reports 13:3, pages 235-244.
Crossref
Ryo Inose, Kouichi Hosomi, Binawool Park, Mai Fujimoto & Mitsutaka Takada. (2014) Signal Detection of hepatitis B and hepatitis C by molecularly-targeted drugs for cancer:. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 40:5, pages 268-277.
Crossref
Jessica P. Hwang, John M. Vierling, Andrew D. Zelenetz, Susan C. Lackey & Rohit Loomba. (2012) Hepatitis B virus management to prevent reactivation after chemotherapy: a review. Supportive Care in Cancer 20:11, pages 2999-3008.
Crossref
Thomas E. Witzig. 2010. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer 169 218 .
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.